APA (7th ed.) Citation

Hao, C., Wang, X., Shi, Y., Tong, Z., Li, S., Liu, X., . . . Zhang, L. (2025). Combination Therapy of Pyrotinib and Metronomic Vinorelbine in HER2+ Advanced Breast Cancer after Trastuzumab Failure (PROVE): A Prospective Phase 2 Study. Cancer Research & Treatment, 57(2), 434. https://doi.org/10.4143/crt.2024.340

Chicago Style (17th ed.) Citation

Hao, Chunfang, et al. "Combination Therapy of Pyrotinib and Metronomic Vinorelbine in HER2+ Advanced Breast Cancer After Trastuzumab Failure (PROVE): A Prospective Phase 2 Study." Cancer Research & Treatment 57, no. 2 (2025): 434. https://doi.org/10.4143/crt.2024.340.

MLA (9th ed.) Citation

Hao, Chunfang, et al. "Combination Therapy of Pyrotinib and Metronomic Vinorelbine in HER2+ Advanced Breast Cancer After Trastuzumab Failure (PROVE): A Prospective Phase 2 Study." Cancer Research & Treatment, vol. 57, no. 2, 2025, p. 434, https://doi.org/10.4143/crt.2024.340.